for the last few years I have not understood why everyone thought it was so obvious that the drug would be approved. The twice a day has side effects and the weekly drug was only tested in about 200 patients. I do not think the safety database was large enough.
then again why did the fda give them guidance that such a small trial would be acceptable?
News 
Market Data 
Discover 
